Literature DB >> 29742446

Quantification of Müllerian Inhibiting Substance/Anti-Müllerian Hormone polypeptide by isotope dilution mass spectrometry.

Gail Whiting1, Jackie Ferguson2, Min Fang2, David Pepin3, Patricia Donahoe3, Paul Matejtschuk2, Chris Burns2, Jun X Wheeler2.   

Abstract

Measurement of serum concentrations of Müllerian inhibiting substance (MIS), also known as anti-Müllerian Hormone (AMH) by immunoassay is gaining clinical acceptance and widespread use for the diagnosis of ovarian conditions and for prediction of the response to ovarian stimulation protocols as part of assisted reproductive therapies. Provision of an International Standard to harmonize immunoassay methods is required. It is desirable for the content of a future International Standard to be assigned in mass units for consistency with the units reported by current methods. Isotope dilution mass spectrometry (IDMS), a physicochemical method with traceability to the SI (Système International d'Unités) unit of mass, is a candidate approach to provide orthogonal data to support this mass assignment. Here, we report on the development of an IDMS method for quantitation of AMH using three peptides from different regions of the AMH monomer as surrogates for the measurement of AMH. We show the sensitivity and linearity of the standard peptides and demonstrate the reproducibility and consistency of the measurement amongst the three peptides for determining the AMH content in buffered preparations and in trial preparations of recombinant AMH, lyophilised in the presence of an excess of bovine casein. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-Müllerian hormone; Infertility; Mass spectrometry; Müllerian inhibiting substance; Selected reaction monitoring; Signature peptide

Mesh:

Substances:

Year:  2018        PMID: 29742446     DOI: 10.1016/j.ab.2018.05.006

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Neoadjuvant Treatment With Müllerian-Inhibiting Substance Synchronizes Follicles and Enhances Superovulation Yield.

Authors:  Motohiro Kano; Jennifer Y Hsu; Hatice D Saatcioglu; Nicholas Nagykery; LiHua Zhang; Mary E Morris Sabatini; Patricia K Donahoe; David Pépin
Journal:  J Endocr Soc       Date:  2019-07-22

2.  Establishment of a WHO Reference Reagent for anti-Mullerian hormone.

Authors:  Jackie Ferguson; Jason Hockley; Peter Rigsby; Chris Burns
Journal:  Reprod Biol Endocrinol       Date:  2020-08-15       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.